6 comments

[ 2.8 ms ] story [ 23.2 ms ] thread
The article states:" We therefore hypothesise[sic] that diabetes and hypertension treatment with ACE2-stimulating drugs increases the risk of developing severe and fatal COVID-19."

From the paper you cannot conclude that, in general, "Ibuprofen may increase the risk of Covid-19 complications ", because the paper applies to people with hypertension and/or diabetes.

Nonetheless, for other reasons, it has been recommended that one take paracetamol (acetominophen, tylenol) instead of ibuprofen or naproxen for Covid-19:

https://www.theguardian.com/world/2020/mar/14/anti-inflammat...

Please also check this twitter thread, according to the Medical University of Vienna and the German Robert Koch Institute this is not confirmed. WhatsApp messages with a similar message (and a “quote” of the Medical University of Vienna) are deemed to be fake news.

https://mobile.twitter.com/MedUni_Wien/status/12387995614156...

Title is too broad. From TFA:

> We therefore hypothesise that diabetes and hypertension treatment with ACE2-stimulating drugs increases the risk of developing severe and fatal COVID-19.

This has been tweeted by the French health minister today, and reinforced during a press conference and all over the news.
Title needs fixing: actual title is “Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?”.

Ibuprofen is mentioned as a minor addition: “ACE2 can also be increased by thiazolidinediones and ibuprofen”

Does this mean it’s not hypertension itself but the medication to treat it that results in a higher risk of severe Covid-19?